# Metronidazole

## Metronidazole inj 500mg/100mL

##### 

| TAH Drug Code      | [IMETR](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IMETR)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Infections with anaerobic causative agents. Infections of the GIT, after colon surgery, in peritonitis, purulent diseases of the pelvic cavity, infections of the female genital tract as well as puerperal fever.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Dosing             | (仿單) Anaerobic infections: Adults and children >= 12 years: 500 mg Q8H IV at a rate of 25 mg/minute (5 mL/minute) or 22.5 mg/kg/day; children < 12 years: 22.5 mg/kg/day once daily. Pre- and post-operation: 500-1500 mg at a rate of 25 mg/minute (5 mL/minute). *****NEONATE ANTIBIOTICS DOSE***** Metronidazole: Loading dose: 15 mg/kg; (參考 馬偕), IV drip> 0.5-1hour, at conc < 8mg/ml Maintenance dose: as below Body weight <1kg ge<=7day 7.5mg/kg QD  Age 8-14 day 7.5mg/kg QD  Age 15-28 day 7.5 mg/kg QD Body weight 1-2kg ge<=7day 7.5mg/kg Q12H  Age 8-14 day 7.5 mg/kg Q12H  Age 15-28 day 7.5 mg/kg Q12H Body weight >2kg Age<=7day 7.5mg/kg Q8H  Age 8-14 day 10 mg/kg Q8H  Age 15-28 day 10mg/kg Q8H |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Contraindications  | Hypersensitivity. Blood dyscrasias.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Adverse Effects    | GI disturbances, somnolence, vertigo, headache, ataxia, darkening of urine, itch, cutaneous eruption, peripheral neuropathy. Gastrointestinal: Abdominal discomfort (7%), Loss of appetite, Metallic taste, Nausea and vomiting (4%) Immunologic: Jarisch Herxheimer reaction Neurologic: Dizziness (1% to 4% ), Headache (tablets, 15% to 18%; vaginal gel, 5% ), Peripheral neuropathy Reproductive: Candida infection of genital region, Symptomatic cervicitis/vaginitis (10%), Vaginal discharge (12%) Other: Drug interaction with alcohol, Disulfiram-like reaction                                                                                                                                                |
| Pregnancy          | Human Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Lactation          | Hold Breast Feeding                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |

## Metrozole 250mg

##### 

| TAH Drug Code      | [OMETR](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OMETR)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Vaginitis caused by Trichomonas. Amebiasis & metronidazole-susceptible anaerobic infection.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Dosing             | (仿單) Adults: Anaerobic infections: 7.5 mg/kg Q6H for 7 days (max 1 g/dose; 4 g/day).Helicobacter pylori: 500 mg orally Q8H in combination with bismuth and other antibiotics for 1-2 weeks. Amebiasis: 500-700 mg orally Q8H for 5-7 days. Trichomoniasis: 2 g orally as a single dose, 1 g q12h for 1 day or 250 mg Q8H for 7 days. Dracunculiasis: 250 mg Q8H for 10 days. Children: Anaerobic infections:7.5 mg/kg Q6H or 10 mg/kg Q8H. Amebiasis: 11.6-16.7 mg/kg Q8H for 10 days. Trichomoniasis: 5 mg/kg Q8H for 7 days. Dracunculiasis: 8.3 mg/kg (max 250 mg/dose) Q8H for 10 days. |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Contraindications  | Blood dyscrasias. Active CNS disease.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Adverse Effects    | GI disturbances; peripheral neuropathy; drowsiness; leukopenia; rarely, skin reactions, darkening of urine, anaphylaxis, encephalopathy. Gastrointestinal: Abdominal discomfort (7%), Loss of appetite, Metallic taste, Nausea and vomiting (4%) Immunologic: Jarisch Herxheimer reaction Neurologic: Dizziness (1% to 4% ), Headache (tablets, 15% to 18%; vaginal gel, 5% ), Peripheral neuropathy Reproductive: Candida infection of genital region, Symptomatic cervicitis/vaginitis (10%), Vaginal discharge (12%) Other: Drug interaction with alcohol, Disulfiram-like reaction        |
| Pregnancy          | Human Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |

